Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Interferon alfa-n3

EU orphan designation number: EU/3/15/1568   
Active ingredient: Interferon alfa-n3
Indication: Treatment of Middle East respiratory syndrome
Sponsor: NV Hemispherx BioPharma Europe
Leopold De Vriesstraat 26, 2600 Berchem, België

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/11/2015 Orphan designation EMA/OD/093/15 (2015)8018 of 11/11/2015
22/12/2015 Corrigendum (2015)9753 of 18/12/2015